Deal Watch: Cigna Acquisition Of Express Scripts OKed By US Justice Dept.
Executive Summary
It remains unclear what impact the consolidation within the drug-distribution sector may have on pricing. Pfizer partners with France’s Cytoo for its new gene therapy approach to DMD, while Gilead teams with Precision BioSciences for its goal to cure HBV.
You may also be interested in...
Deal Watch: Iktos Doubles Its 2022 Alliance Tally In Agreements With Galapagos, Zealand
French AI-driven drug design firm will employ multiple technology platforms in latest tie-ups. Apellis looks to augment Empaveli-led portfolio in C3 complement R&D alliance with Affilogic.
Deal Watch: Merck's Busy Stretch Includes Collaborations With Dewpoint, Zymeworks
Bristol makes its own deal with Celgene ally Dragonfly, while Gilead ends virology partnerships with Durect and Precision BioSciences.
IPO Update: Gottlieb’s Resignation Pulls Down Five Of Eight Newly Public Biopharmas
There have been eight US biopharma IPOs in 2019, but only three are trading above their launch price – a big change from just three days ago.